What top creators are saying about HSBC Holdings plc(HSBC)

Mentioned as an earnings-calendar item, without an earnings estimate or investment recommendation.

HSBC was mentioned in an earnings-calendar discussion without stock-specific investment analysis.

Mentioned only as an upcoming earnings report; no company-specific forecast or recommendation was provided.

Faces margin compression and operational friction from heavy cross-border compliance burdens, forcing defensive debanking measures.

Beneficiary of massive mainland Chinese capital inflows into Hong Kong's wealth management sector.

Major institutional partner utilizing the Canton Network for capital market applications.

Representing a bear case for labor with plans to cut up to 20,000 jobs as it automates middle and back-office functions.

Contrasted with the new bank Erebor, HSBC was mentioned as a bank that has faced issues with illicit activities, implying a comparative weakness.

Used as a negative example of a bank with high regulatory and reputational risk, having 'faced massive fines for servicing illicit actors and cartels'.

Exemplifies a culture of 'overcompliance' and a highly risk-averse posture by refusing to re-engage with Iran even after sanctions were eased. This caution protects the bank from fines but may also mean forgoing growth opportunities in politically complex markets.

Mentioned as a well-performing European bank, up 70%, highlighting that specific companies in the region can offer strong returns despite broader economic concerns.

Mentioned as a key institutional backer of the Canton project, providing validation for Canton's focus on bringing institutional finance on-chain.

Mentioned as a major traditional finance partner and investor in the Canton blockchain project.

Participating in a blockchain solution test with Swift and ConsenSys on an Ethereum testnet, showing continued institutional engagement with the technology.

A research paper co-authored with IBM on using quantum computing for bond trading was heavily criticized as flawed and "100% bullshit," suggesting the company's positive results in this specific research area are not credible.